ACE Gene Polymorphism in Peripheral Vascular Disease[*]

Abstract

Peripheral vascular disease is an atherosclerotic process. It has been suggested that angiotensin converting enzyme insertion/deletion polymorphism is associated with atherosclerosis. The aim of this study was to investigate the role of the insertion/deletion polymorphism of the angiotensin-converting enzyme in Turkish patients with peripheral vascular disease in Western part of Turkey. We also investigated the relationship between serum angiotensin converting enzyme activity and distribution of genotypes in both patients and control group. The study group consisted of 78 patients with peripheral vascular disease. The control group consisted of 73 healthy adults. Serum angiotensin converting enzyme activities in patients were higher than those of the control group (p<0.05). Angiotensin converting enzyme genotype frequencies in patients were observed as 28.2%, 18% and 53.8% for DD, II and ID polymorphism, respectively. These frequencies in controls were 42.5%, 20.5% and 37% for DD, II and ID, respectively. Serum angiotensin converting enzyme activities in both groups with II genotype were significantly lower than those with ID and DD genotype (p<0.05). Although conflicting results have been reported about this polymorphism in patients with peripheral vascular disease, we suggest that the angiotensin converting enzyme ID genotype may be a risk factor for peripheral vascular disease.

Serum - angiotensin converting enzyme - polymorphism - genotype - peripheral vascular disease

References

• 1 Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease.  Clin Chem Lab Med. 2002;  40 256-265
• 2 Pilati M, Cicoira M, Zanolla L, Nicoletti I, Muraglia S, Zardini P. The role of angiotensin-converting enzyme polymorphism in congestive heart failure.  Congest Heart Fail. 2004;  10 87-93
• 3 Hooper WC, Dowling NF, Wenger NK, Dilley A, Ellingsen D, Evatt BL. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans.  Am J Hematol. 2002;  70 1-8
• 4 Tseng CH, Tseng CP. Lack of association between angiotensin-converting enzyme gene polymorphism and peripheral vascular disease in type 2 diabetic patients in Taiwan.  Circ J. 2002;  66 1014-1018
• 5 Kawamoto R, Kohara K, Tabara Y, Mıkı T. An interaction between systolic pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis.  Hypertens Res. 2002;  25 875-880
• 6 Hessner MJ, Dinauer DM, Kwiatkowski R, Neri B, Raife TJ. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors.  Clin Chem. 2001;  47 1879-1884
• 7 Taute BM, Seifert H, Taute R, Glaser C, Podhaisky H. Angiotensin-converting enzyme gene insertion/deletion polymorphism and carotid artery wall thickness in patients’ peripheral arterial occlusive disease.  Int Angiol. 2000;  19 337-344
• 8 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells.  Nucl Acids Res. 1988;  16 1215
• 9 Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptdyl carboxypeptidase).  Nucl Acids Res. 1992;  20 1433
• 10 Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism: I and I from some different countries.  Clin Appl Thromb Hemost. 2004;  10 179-182
• 11 Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H. et al . The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample.  Endocr J. 2003;  50 393-398
• 12 Molnar GA, Wagner Z, Wagner L, Melegh B, Koszegi T, Degrell P. et al . Effect of ACE gene polymorphism on carbohydrate metabolism on oxidative stress and on end-organ damage in type-2 diabetes mellitus.  Orv Hetil. 2004;  145 855-859
• 13 Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors.  Diabet Med. 2003;  20 988-995
• 14 Renner W, Pabst E, Paulweber B, Malaimare L, Iglseder B, Wascher TC. et al . The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease.  Atherosclerosis. 2002;  165 175-178
• 15 Qadar Pasha MA, Khan AP, Kumar R, Ram RB, Grover SK, Srivastava KK. et al . Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins.  J Biosci. 2002;  27 ((Suppl 1)) 67-70

1 The paper has already been presented at the 16th IFCCFESCC European Congress of Clinical Chemistry and Laboratory Medicine, Glasgow 2005.

Correspondence